Search

everythinglearnresearchcommunity

for

Search:↓

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Using tissue adhesive in hair transplants improves results and patient satisfaction, with fewer complications.

Mesotherapy is more effective than topical spray for female hair loss treatment.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

New effective scar treatments are urgently needed due to the current options' limited success.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Some chemotherapy can cause permanent hair loss.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Non-immune factors play a significant role in alopecia areata.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

A simplified method was introduced to diagnose most hair loss types by examining the patient's history and scalp, with some cases needing further tests.

The document concludes that advancements in hair restoration surgery have led to more natural results and patient satisfaction, with hope for future improvements in treatment.

Hair loss common in men and women, limited treatments available.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Beard hair can be used for hair transplants in severe alopecia cases, with minimal complications and good results.

Treating ovarian-related inflammation may help hair regrowth in women with alopecia areata.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Hair loss needs more research for better treatments.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Both mouse and rat models are effective for testing alopecia areata treatments.

PRP treatment helps hair growth in most cases, but more research needed.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Hair loss treatments work better with lifestyle changes.